Tag Archives: Federal Drug Administration

David Brushwood Interview — Podcast May 1, 2017

Martin Shkreli Isn’t the Only Profiteer in the Pharmaceutical Industry: Why Does the U.S., Alone Among Developed Countries, Allow Life-Saving Prescription Drugs To Be Priced Beyond the Reach Of Many Of the Patients Who Need Them? David Brushwood, professor emeritus of Pharmaceutical Outcomes … Continue reading

Posted in Affordable Care Act, Corruption, Health Care, Health Care Delivery, Health Care Policy, Health Insurance, Interviews, Medicaid, Medicare, National Politics, Pharmaceutical Pricing and Procurement, Podcasts, Public Health Policy | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on David Brushwood Interview — Podcast May 1, 2017